Alnylam Pharmaceuticals, Inc. (ALNY) vs Regeneron Pharmaceuticals, Inc. (REGN)

Alnylam Pharmaceuticals, Inc. and Regeneron Pharmaceuticals, Inc. are both Biotechnology companies. Regeneron Pharmaceuticals, Inc. is the larger, with a market value of $81.3B against $31.2B — 2.6× the size. Regeneron Pharmaceuticals, Inc. trades at the lower P/E: 18.8× against 43.6×. Alnylam Pharmaceuticals, Inc. grew revenue faster over the last twelve months: 95.1% against 9.29%. Regeneron Pharmaceuticals, Inc. has the higher net margin (27.9% vs 16.1%) and the higher return on invested capital (9.34% vs 0.00%). Across the 22 metrics below, Regeneron Pharmaceuticals, Inc. leads on 16 and Alnylam Pharmaceuticals, Inc. on 6.